S 3174
116th Congress
Senate
Health
Administrative law and regulatory procedures
Child health
Civil actions and liability
Congressional oversight
Consumer affairs
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug, alcohol, tobacco use
Food and Drug Administration (FDA)
Government information and archives
Government studies and investigations
Health care coverage and access
Health programs administration and funding
Health promotion and preventive care
Marketing and advertising
Mental health
Minority health
Racial and ethnic relations
Retail and wholesale trades
Reversing the Youth Tobacco Epidemic Act of 2020
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 9, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan 9, 2020
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Reversing the Youth Tobacco Epidemic Act of 2019
This bill revises requirements related to the safety, sale, and advertisement of tobacco products, including electronic nicotine delivery systems (e.g., e-cigarettes, e-hookah, e-cigars, and vape pens).
Among other requirements, the bill
- requires the Food and Drug Administration (FDA) to implement regulations to require color graphics on the labeling of cigarette packages, depicting the negative health consequences of smoking;
- requires the FDA to apply regulations on tobacco products to all tobacco products, including e-cigarettes;
- prohibits the retail online sale of tobacco products, including electronic nicotine delivery systems;
- prohibits flavors other than tobacco in a tobacco product;
- prohibits the use of flavored products in an electronic nicotine delivery system, except in specified circumstances;
- increases the user fees that the FDA collects from manufacturers and importers;
- directs the FDA to regulate products containing synthetic nicotine (not made or derived from tobacco);
- establishes a demonstration grant program to develop strategies for smoking cessation in medically underserved communities;
- increases civil penalties for certain violations of restrictions on the sale of tobacco products; and
- requires the Government Accountability Office to study e-cigarettes.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related & companion bills
2
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). S. 3174: Reversing the Youth Tobacco Epidemic Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-S-3174/
"S. 3174: Reversing the Youth Tobacco Epidemic Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-3174/.
S. 3174, 116th Cong. (2026), https://openamerica.io/bill/116-S-3174/.
[S. 3174: Reversing the Youth Tobacco Epidemic Act of 2020](https://openamerica.io/bill/116-S-3174/)